國家衛生研究院 NHRI:Item 3990099045/7940
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 917488      線上人數 : 1385
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7940


    題名: EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
    作者: Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY
    貢獻者: National Institute of Cancer Research;Division of Biostatistics and Bioinformatics
    摘要: Background: Activation of the EGFR/PI3K/AKT pathway is known for the crucial role in tumorigenesis of oral cancer. Our study focused to analyze the aberrations of the regulatory factors which lead to over-activation of this pathway. Patients and methods: A series of studies was conducted with application of the archival oral cancer tissue specimens which was obtained from patients who received surgical resection. For the factors in interest, we studied their protein expression and gene copy number (GCN) by immunohistochemical staining and real-time polymerase chain reaction, respectively. Statistical assessment was then arranged to determine their association and the impact to survival outcomes. Results: In the total108 samples examined, the activation of AKT was evidenced in 86.9% by identification of the cytoplasmic phosphorylated AKT (pAKT). There were 63.9% of the samples with expression of membranous wild-type EGFR, and 49.1% of the samples with undetectable PTEN in the tumor tissue. Judgment of EGFR variant III (EGFRvIII) showed that 75.0% of the samples were positive, with 38.5% low expression and the remaining 31.5% high expression. Studies of the PIK3CA gene revealed alteration of GCN in 24.8% of the samples and hotspot point mutation in 2.3% of the samples. Those of the EGFR gene showed evidence of GCN amplification in 49.0% of the samples, and were in association to expression of the wild-type protein but not EGFRvIII. Further analysis of EGFRvIII negative/low or high expression was in correlation to the T classification and the disease stage. For the survival analyses, classification according to pAKT or EGFRvIII both led to significantly different Kaplan-Meier curves. Moreover, simultaneous judgment by the status of EGFR wild type and variant III also served to predict the patient survival. By the multivariate analysis, individual factors such as pAKT, EGFRvIII and the disease stage were further suggested as the determinants of the survival outcome. Conclusions: Our investigation showed that in oral cancers, aberrations in the regulatory factors of the AKT pathway were frequent. Expression of EGFRvIII and pAKT were negative predictors for the patient survival.
    日期: 2013-04
    關聯: Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
    Link to: http://dx.doi.org/10.1158/1538-7445.AM2013-2390
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000336426100004
    顯示於類別:[張俊彥] 會議論文/會議摘要
    [張光裕] 會議論文/會議摘要
    [鄒小蕙] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000331212904321.pdf26KbAdobe PDF582檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋